Understanding Basic Stock Data: Immunomedics, Inc. (IMMU)

In the past 52-week period, shares of Immunomedics, Inc. (NASDAQ:IMMU) have moved within the range of $2.32 to $14.48. On the stock’s most recent trading day, the company’s shares ended the regular session at $10.44, which is 27.9% higher than its 52-week high.

Immunomedics, Inc. (IMMU) has demonstrated a 20-day simple moving average (SMA) of -4.96%, and a 50-day SMA of -11.11%. This public company’s current market capitalization stands at $1.28 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Immunomedics, Inc. (IMMU) is Buy.

When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Jun. 2017, Immunomedics, Inc. (IMMU) delivered a 73.99% surprise with its net revenue.

Meanwhile, during the same quarter Immunomedics, Inc. (IMMU) delivered a -289.29% earnings surprise. Net earnings for the quarter were posted at -$0.48 per share, whereas Wall Street had forecast -$0.12 per share.

Ownership at Immunomedics, Inc. (IMMU), According to Most Recent SEC Filings

A public company’s latest 13F filings tell investors important details about institutional ownership. Immunomedics, Inc. (IMMU) has 0 billion shares outstanding currently, 61.32% of which belong to institutional investors. Those institutional holdings amount to $0.94 billion.

Additionally, according to the most recent 13F filing from Immunomedics, Inc. (IMMU), there were 22 new positions totaling 10,607,583 shares of the company’s stock. There were 20 sold out positions, on the other hand, totaling 6,192,979 shares.

Short, Medium and Long Term Indicators

Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Immunomedics, Inc. (IMMU) has had a 20-day average volume of 2,211,175 shares, with an average of 60% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 2,548,138 shares, with an average of 50% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 2,519,018 shares with 67% of long-term indicators pointing to Buy.